000 02216nam##2200313za#4500
0019.695823
003CaOODSP
00520210624234742
007cr |||||||||||
008150407|1991||||xxc|||||o    f|0| 0 eng|d
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH42-2/47-1991E-PDF
1101 |aCanada.|bHealth Canada. |bTherapeutic Products Directorate.
24510|aTherapeutic Products Programme questions and answers / |h[electronic resource]|cprepared under the direction of the Therapeutic Products Programme, Health Canada.
24615|aDrugs Directorate questions and answers
260 |aOttawa - Ontario : |bHealth Canada. |cJanuary 1991.
300 |a58p.|bfigs.
500 |a"Please note that the following document is NOT a new Therapeutic Products Programme guideline. Hard copies of this guideline are no longer available. For the convenience of clients and stakeholders we are making this guideline available electronically."--p.1 of 58. Incorrect catalogue number (H42-2/47-1991IN) and ISBN (0-662-58022-2) for the bilingual print edition copied in this electronic publication.
5203 |a[The]...purpose is to assist drug manufacturers, distributors, and importers in quickly obtaining answers to those questions most often directed to Directorate staff.... The publication contains information on the interpretation of the Food and Drugs Act and Regulations, the Cosmetic Regulations, and the Narcotic Control Act and Regulations, the manufacture of both prescription and nonprescription drugs, the import and export of drug products, and the submission of samples for branch approval.--Introduction, p.5 of 58.
590 |a12-17-Supp|b2012-04-20
69007|aGovernment policy|2gcpds
69007|aDrugs|2gcpds
69007|aPharmaceutical industry|2gcpds
77508|tDirection des médicaments questions et réponses / |w(CaOODSP)9.639912
7760#|tDrugs Directorate: questions and answers / |w(CaOODSP)9.654327
7760#|tDirection des médicaments: questions et réponses / |w(CaOODSP)9.654328
85640|ahttp://publications.gc.ca|qPDF|s194 KB|uhttps://publications.gc.ca/collections/Collection/H42-2-47-1991E.pdf